Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Sally Beauty Holdings
SBH
$1.55B
| $582K | 0.02% |
23,223
+8,689
| +60% | +$224K |
|
|
SCS
452
DELISTED
Steelcase
SCS
| $582K | 0.02% |
38,471
-16,833
| -30% | -$277K |
|
|
HRC
453
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $581K | 0.02% |
14,000
+3,500
| +33% | +$136K |
|
|
ESRX
454
DELISTED
Express Scripts Holding Company
ESRX
| $581K | 0.02% |
8,380
+1,480
| +21% | +$104K |
|
|
TRAK
455
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $580K | 0.02% |
12,800
+1,877
| +17% | +$81.2K |
|
456
AES
AES
$10.5B
| $579K | 0.02% |
37,226
-1,022
| -3% | -$14.7K |
|
|
CTCT
457
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $577K | 0.02% |
17,971
-9,014
| -33% | -$251K |
|
458
Vishay Intertechnology
VSH
$4.85B
| $575K | 0.02% |
+37,100
| New | +$550K |
|
459
Matrix Service
MTRX
$311M
| $573K | 0.02% |
17,478
+2,039
| +13% | +$67.3K |
|
460
Nucor
NUE
$55.3B
| $572K | 0.02% |
+11,622
| New | +$596K |
|
461
Ryder
R
$9.58B
| $570K | 0.02% |
6,466
+3,666
| +131% | +$307K |
|
462
Scansource
SCSC
$1.1B
| $569K | 0.02% |
14,951
-5,607
| -27% | -$214K |
|
463
Terex
TEX
$7.6B
| $568K | 0.02% |
+13,823
| New | +$562K |
|
|
SYNT
464
DELISTED
Syntel Inc
SYNT
| $567K | 0.02% |
13,200
-2,600
| -16% | -$107K |
|
465
Assured Guaranty
AGO
$3.27B
| $565K | 0.02% |
+23,061
| New | +$572K |
|
|
LPT
466
DELISTED
Liberty Property Trust
LPT
| $565K | 0.02% |
+14,909
| New | +$566K |
|
|
PDCO
467
DELISTED
Patterson Companies, Inc.
PDCO
| $564K | 0.02% |
14,271
-1,945
| -12% | -$78.6K |
|
468
Unum
UNM
$13.9B
| $563K | 0.02% |
+16,200
| New | +$553K |
|
469
Hershey
HSY
$37.5B
| $559K | 0.02% |
5,740
-884
| -13% | -$86.7K |
|
|
OPLN
470
Openlane
OPLN
$4.08B
| $559K | 0.02% |
46,301
+24,415
| +112% | +$282K |
|
|
CERN
471
DELISTED
Cerner Corp
CERN
| $559K | 0.02% |
+10,840
| New | +$570K |
|
|
ASRT
472
DELISTED
Assertio
ASRT
| $558K | 0.02% |
669
-392
| -37% | -$302K |
|
473
Carter's
CRI
$1.31B
| $558K | 0.02% |
+8,092
| New | +$588K |
|
474
Andersons Inc
ANDE
$2.31B
| $557K | 0.02% |
10,800
-3,800
| -26% | -$209K |
|
475
PG&E
PCG
$38.8B
| $557K | 0.02% |
11,600
-10,500
| -48% | -$476K |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.